HPV16E7 mediates HADC chromatin repression and downregulation of MHC class I genes in HPV16 tumorigenic cells through interaction with an MHC class I promoter

This publication has 45 references indexed in Scilit:

• Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
  JNCI Journal of the National Cancer Institute, 2000
• Multiple Genetic Alterations Cause Frequent and Heterogeneous Human Histocompatibility Leukocyte Antigen Class I Loss in Cervical Cancer
  The Journal of Experimental Medicine, 2000
• Telomerase activation by the E6 gene product of human papillomavirus type 16
  Nature, 1996
• Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression
  British Journal of Cancer, 1995
• A Mutational Analysis of the Amino Terminal Domain of the Human Papillomavirus Type 16 E7 Oncoprotein
  Virology, 1994
• Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours
  British Journal of Cancer, 1994
• Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein.
  Molecular and Cellular Biology, 1993
• Evaluation of multiple biologie parameters in cervical carcinoma: high macrophage infiltration in HPV-associated tumors
  International Journal of Gynecologic Cancer, 1993
• Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation
  Cell, 1991
• MHC-Restricted Cytotoxic T Cells: Studies on the Biological Role of Polymorphic Major Transplantation Antigens Determining T-Cell Restriction-Specificity, Function, and Responsiveness
  Published by Elsevier ,1979